Undisclosed Tissue Therapeutic(s)
Soft tissue defects and organ dysfunction
Pre-clinicalActive
Key Facts
Indication
Soft tissue defects and organ dysfunction
Phase
Pre-clinical
Status
Active
Company
About Cellbricks Therapeutics
Cellbricks Therapeutics is a pioneering biotech company aiming to address the critical unmet need for tissue restoration by developing biofabricated human tissue therapeutics. Its core technology integrates a proprietary light-based biofabrication system with AI-driven tissue engineering software to produce scalable and precise living tissue implants. The company is in the pre-clinical stage, backed by institutional investors and strategic hires like former BioNTech CFO Michael Kring, and is advancing its platform towards clinical applications for soft tissue defects and organ dysfunction.
View full company profile